Searched for
ABBOT PHARMACEUTICALS
Ajay Piramal explains pharma business demerger, growth prospects and more“Whatever we committed to the market we have delivered and probably a little more than that. We had committed that we will bring in equity ...- Continued pressure on Horlicks, destocking negatively impacted nutrition business: GSK
- Donald Trump's policy not to hit Indian IT, pharma firms: Union Minister HN Ananth KumarKumar was replying to a query on Trump's policy of protectionism at a news conference to announce the "Indian Pharma" conference.
- Pharma industry grows 29% to Rs 2.04 lakh crore in 2015-16In terms of FDI inflows, the sector attracted FDI worth $2.25 billion during April 2014 to March 2016 period.
- FDI up to 74% in brownfield pharma under automatic routeThe government today allowed up to 74 per cent foreign direct investment in the existing pharmaceutical companies through automatic route.
- Government weighs relaxing FDI norms in brownfield pharma companiesAccording to a proposal, FDI up to 49% should be allowed through the automatic route and anything beyond through approval of the FIPB, sour...
- Government to conduct study to assess impact of FDI in pharma industryThe experts would look into the impact of foreign direct investment in the brownfield pharmaceutical companies and access to affordable med...
- Govt to review FDI policy in pharma sector on MondayGovernment will take up the issue of tightening FDI in existing pharmaceutical companies in the wake of concerns over multinationals taking...
- Is FDI in pharma giving desired results, wonders DIPPThe DIPP said current norms must lay down the foundation of what should be the nature of Indian drug companies in the long term.
- DIPP to send proposal to PMO on review of pharma FDI policyThe DIPP will soon send a comprehensive proposal to the PMO for review of the current policy for FDI in existing drug companies.
- DIPP wants relook of FDI policy in pharma at PM levelWith no let up in multinationals seeking nod to acquire stake in Indian pharma firms despite government putting norms to check it.
- Piramal Group plans to build Rs 15k crore financial services businessWe want to do three-four big ticket structured transactions every year and strengthen the NBFC business, says Piramal Group chief Ajay Pira...
- CCI seeks changes in Competition Act to deal with all M&AsThe government, he added, should amend the law in such a way so that it can have powers to prescribe different threshold limits for M&As fo...
- Let all pharmaceutical mergers and acquisitions be cleared by CCI: Plan panel groupA Planning Commission expert group recommended that all M&As in the pharma industry should be cleared by CCI.
- Review on FDI in Indian pharma sector soon, says Pranab MukherjeeAmidst a debate whether FDI in pharma sector should be regulated ,Pranab Mukherjee said a decision on the issue would be taken.
- Ministers' panel to look into FDI in pharma sectorThe immediate trigger for the move was the acquisition of Ahmedabad-based Paras Pharmaceuticals by British consumer goods and healthcare fi...
- FDI curbs on only govt-aided pharma cosThe government has clarified that FDI in greenfield pharmaceutical projects will continue unhindered, but companies that receive government...
- India rejects Abbot lab's patent application for HIV drugIndia has rejected a drug patent application of a US multi-national pharma company, paving way for easy access to an important life-saving ...
- Finmin opposes plans to put curbs on FDI in pharma sectorThe finance ministry has redflagged a move to impose curbs on foreign direct investment in the pharmaceutical sector.
- Ranbaxy recieves US approval for anti-bacterial drugUS Food and Drug Administration's has given the approval to manufacture and market anti-bacterial drug oral Clarithromycin in multiple stre...
Load More
